Literature DB >> 30772641

Direct oral anticoagulant (DOAC)-mediated vasodilation: Role of nitric oxide.

Jon Mabley1, Jignesh P Patel2, Abdelrahman Sayed1, Roopen Arya3, Greg Scutt4.   

Abstract

Entities:  

Keywords:  Apixaban; Endothelial; Factor Xa inhibitors; Nitric oxide; Rivaroxaban; Vasodilation

Year:  2019        PMID： 30772641     DOI： 10.1016/j.thromres.2019.02.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

1.  Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models.

Authors:  Armond Daci; Lorenzo Da Dalt; Rame Alaj; Shpejtim Shurdhiqi; Burim Neziri; Rrahman Ferizi; Giuseppe Danilo Norata; Shaip Krasniqi
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

Review 2.  Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease.

Authors:  Sylwester Rogula; Aleksandra Gąsecka; Tomasz Mazurek; Eliano Pio Navarese; Łukasz Szarpak; Krzysztof J Filipiak
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

3.  Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.

Authors:  Sergi Torramade-Moix; Marta Palomo; Manel Vera; Didac Jerez; Ana Belen Moreno-Castaño; M Urooj Zafar; Jordi Rovira; Fritz Diekmann; Joan Carles Garcia-Pagan; Gines Escolar; Aleix Cases; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.